Business Analysis for Diabetic Products

Diabetes has become a matter of huge concern as it is a cosmopolitan disorder with an estimated 285 million diabetic, corresponding to 6.4 percentage of world’s adult population, are living with diabetes. The diabetic population is expected to explode to 438 million by 2030, corresponding to 7.8 percentage of the adult population. The rate of this disorder is on it’s highest at increase. As it is a leading problem globally there is also a gigantic demand for the diagnosis and screening, medication. The global type 2 diabetes market is set to almost double from $31.2 billion in 2015 to $58.7 billion by 2025, representing a compound annual growth rate of 6.5%, according to research and consulting firm Global Data.

The pharmaceutical business is attaining a top places in this field of medication.   

  • Insulin biosimilars development
  • Novel paradigms

Related Conference of Business Analysis for Diabetic Products

February 09-10, 2026

20th International Conference on Endocrinology, Diabetes and Metabolism

Singapore City, Singapore
February 12-13, 2026

5th Global Summit on Physiology and Metabolism of Thyroid

Singapore City, Singapore
February 23-24, 2026

19th International Summit on Diabetes

London, UK
February 25-26, 2026

16th World Congress on Endocrinology and Diabetes

Paris, France
March 26-27, 2026

7th Global summit on Diabetes and Endocrinology

Amsterdam, Netherlands
May 14-15, 2026

7th World Summit on Diabetes

Rome, Italy
May 18-19, 2026

57th Annual Congress on Endocrinology and Diabetes Research

Aix-en-Provence, France

Business Analysis for Diabetic Products Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in